Pharmacotherapy management of schizophrenia for family physicians
Canadian family physicians likely encounter 1 or 2 new patients per year with signs or symptoms of schizophrenia. Although antipsychotic treatment of schizophrenia is generally the responsibility of a psychiatrist, family physicians play an important role in the long-term management of schizophrenia...
Gespeichert in:
| Veröffentlicht in: | Canadian family physician 2021-05, Vol.67 (5), p.350-354 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 354 |
|---|---|
| container_issue | 5 |
| container_start_page | 350 |
| container_title | Canadian family physician |
| container_volume | 67 |
| creator | Bool, Japheth Crawley, Alex Wanson, Annabelle Davis, Breanna Halpape, Katelyn |
| description | Canadian family physicians likely encounter 1 or 2 new patients per year with signs or symptoms of schizophrenia. Although antipsychotic treatment of schizophrenia is generally the responsibility of a psychiatrist, family physicians play an important role in the long-term management of schizophrenia, including the management of antipsychotic adverse effects. Additionally, family physicians might initiate antipsychotic treatment for patients experiencing psychosis when immediate referral to a psychiatrist is not possible. Antipsychotic medications are the mainstay of schizophrenia management and attaining a stable medication regimen as soon as possible following diagnosis helps to prevent future disability. Unfortunately, antipsychotic medication nonadherence and adverse effects are common in schizophrenia management, making the goal of attaining a stable medication regimen challenging to achieve. Here, Bool et al provides an overview of pharmacotherapy management of schizophrenia for family physicians through a case-based approach. |
| doi_str_mv | 10.46747/cfp.6705350 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8115962</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2526303775</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-ce08b5bef5671885b84b3bd4b5abb7dce9cb318e4334c1d58e1faf72c16e5c093</originalsourceid><addsrcrecordid>eNpdkU1LxDAQhoMo7rp68ywFLx7smjRNk70Iy-IXCHpQ8BaSbLLN0jY1aYX66w3uuqjMYWDmmZeZeQE4RXCaFzSnV8q004JCggncA2NEEUlJRtg-GEMIWRrLbyNwFMIawqzIMToEI4xnDBYYjsH8uRS-Fsp1pfaiHZJaNGKla910iTNJUKX9dG3pdWNFYpxPjKhtNSRtOQSrrGjCMTgwogr6ZJsn4PX25mVxnz4-3T0s5o-pylHWpUpDJonUhhQUMUYkyyWWy1wSISVdKj1TEiOmc4xzhZaEaWSEoZlChSYKzvAEXG90217WOg40nRcVb72thR-4E5b_7TS25Cv3wRlCZFZkUeBiK-Dde69Dx2sblK4q0WjXB56RLL4EU0oiev4PXbveN_G8SOGCZRjFmIDLDaW8C8Frs1sGQf7tDY_e8K03ET_7fcAO_jEDfwHbo4wF</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2536823131</pqid></control><display><type>article</type><title>Pharmacotherapy management of schizophrenia for family physicians</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Bool, Japheth ; Crawley, Alex ; Wanson, Annabelle ; Davis, Breanna ; Halpape, Katelyn</creator><creatorcontrib>Bool, Japheth ; Crawley, Alex ; Wanson, Annabelle ; Davis, Breanna ; Halpape, Katelyn</creatorcontrib><description>Canadian family physicians likely encounter 1 or 2 new patients per year with signs or symptoms of schizophrenia. Although antipsychotic treatment of schizophrenia is generally the responsibility of a psychiatrist, family physicians play an important role in the long-term management of schizophrenia, including the management of antipsychotic adverse effects. Additionally, family physicians might initiate antipsychotic treatment for patients experiencing psychosis when immediate referral to a psychiatrist is not possible. Antipsychotic medications are the mainstay of schizophrenia management and attaining a stable medication regimen as soon as possible following diagnosis helps to prevent future disability. Unfortunately, antipsychotic medication nonadherence and adverse effects are common in schizophrenia management, making the goal of attaining a stable medication regimen challenging to achieve. Here, Bool et al provides an overview of pharmacotherapy management of schizophrenia for family physicians through a case-based approach.</description><identifier>ISSN: 0008-350X</identifier><identifier>EISSN: 1715-5258</identifier><identifier>DOI: 10.46747/cfp.6705350</identifier><identifier>PMID: 33980630</identifier><language>eng</language><publisher>Canada: College of Family Physicians of Canada</publisher><subject>Drug therapy ; Family physicians ; Patient care planning ; Prescription drugs ; Psychotropic drugs ; RxFiles ; Schizophrenia ; Side effects</subject><ispartof>Canadian family physician, 2021-05, Vol.67 (5), p.350-354</ispartof><rights>Copyright College of Family Physicians of Canada May 1, 2021</rights><rights>Copyright© the College of Family Physicians of Canada 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-ce08b5bef5671885b84b3bd4b5abb7dce9cb318e4334c1d58e1faf72c16e5c093</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115962/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115962/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33980630$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bool, Japheth</creatorcontrib><creatorcontrib>Crawley, Alex</creatorcontrib><creatorcontrib>Wanson, Annabelle</creatorcontrib><creatorcontrib>Davis, Breanna</creatorcontrib><creatorcontrib>Halpape, Katelyn</creatorcontrib><title>Pharmacotherapy management of schizophrenia for family physicians</title><title>Canadian family physician</title><addtitle>Can Fam Physician</addtitle><description>Canadian family physicians likely encounter 1 or 2 new patients per year with signs or symptoms of schizophrenia. Although antipsychotic treatment of schizophrenia is generally the responsibility of a psychiatrist, family physicians play an important role in the long-term management of schizophrenia, including the management of antipsychotic adverse effects. Additionally, family physicians might initiate antipsychotic treatment for patients experiencing psychosis when immediate referral to a psychiatrist is not possible. Antipsychotic medications are the mainstay of schizophrenia management and attaining a stable medication regimen as soon as possible following diagnosis helps to prevent future disability. Unfortunately, antipsychotic medication nonadherence and adverse effects are common in schizophrenia management, making the goal of attaining a stable medication regimen challenging to achieve. Here, Bool et al provides an overview of pharmacotherapy management of schizophrenia for family physicians through a case-based approach.</description><subject>Drug therapy</subject><subject>Family physicians</subject><subject>Patient care planning</subject><subject>Prescription drugs</subject><subject>Psychotropic drugs</subject><subject>RxFiles</subject><subject>Schizophrenia</subject><subject>Side effects</subject><issn>0008-350X</issn><issn>1715-5258</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpdkU1LxDAQhoMo7rp68ywFLx7smjRNk70Iy-IXCHpQ8BaSbLLN0jY1aYX66w3uuqjMYWDmmZeZeQE4RXCaFzSnV8q004JCggncA2NEEUlJRtg-GEMIWRrLbyNwFMIawqzIMToEI4xnDBYYjsH8uRS-Fsp1pfaiHZJaNGKla910iTNJUKX9dG3pdWNFYpxPjKhtNSRtOQSrrGjCMTgwogr6ZJsn4PX25mVxnz4-3T0s5o-pylHWpUpDJonUhhQUMUYkyyWWy1wSISVdKj1TEiOmc4xzhZaEaWSEoZlChSYKzvAEXG90217WOg40nRcVb72thR-4E5b_7TS25Cv3wRlCZFZkUeBiK-Dde69Dx2sblK4q0WjXB56RLL4EU0oiev4PXbveN_G8SOGCZRjFmIDLDaW8C8Frs1sGQf7tDY_e8K03ET_7fcAO_jEDfwHbo4wF</recordid><startdate>202105</startdate><enddate>202105</enddate><creator>Bool, Japheth</creator><creator>Crawley, Alex</creator><creator>Wanson, Annabelle</creator><creator>Davis, Breanna</creator><creator>Halpape, Katelyn</creator><general>College of Family Physicians of Canada</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>202105</creationdate><title>Pharmacotherapy management of schizophrenia for family physicians</title><author>Bool, Japheth ; Crawley, Alex ; Wanson, Annabelle ; Davis, Breanna ; Halpape, Katelyn</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-ce08b5bef5671885b84b3bd4b5abb7dce9cb318e4334c1d58e1faf72c16e5c093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Drug therapy</topic><topic>Family physicians</topic><topic>Patient care planning</topic><topic>Prescription drugs</topic><topic>Psychotropic drugs</topic><topic>RxFiles</topic><topic>Schizophrenia</topic><topic>Side effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bool, Japheth</creatorcontrib><creatorcontrib>Crawley, Alex</creatorcontrib><creatorcontrib>Wanson, Annabelle</creatorcontrib><creatorcontrib>Davis, Breanna</creatorcontrib><creatorcontrib>Halpape, Katelyn</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Canadian family physician</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bool, Japheth</au><au>Crawley, Alex</au><au>Wanson, Annabelle</au><au>Davis, Breanna</au><au>Halpape, Katelyn</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacotherapy management of schizophrenia for family physicians</atitle><jtitle>Canadian family physician</jtitle><addtitle>Can Fam Physician</addtitle><date>2021-05</date><risdate>2021</risdate><volume>67</volume><issue>5</issue><spage>350</spage><epage>354</epage><pages>350-354</pages><issn>0008-350X</issn><eissn>1715-5258</eissn><abstract>Canadian family physicians likely encounter 1 or 2 new patients per year with signs or symptoms of schizophrenia. Although antipsychotic treatment of schizophrenia is generally the responsibility of a psychiatrist, family physicians play an important role in the long-term management of schizophrenia, including the management of antipsychotic adverse effects. Additionally, family physicians might initiate antipsychotic treatment for patients experiencing psychosis when immediate referral to a psychiatrist is not possible. Antipsychotic medications are the mainstay of schizophrenia management and attaining a stable medication regimen as soon as possible following diagnosis helps to prevent future disability. Unfortunately, antipsychotic medication nonadherence and adverse effects are common in schizophrenia management, making the goal of attaining a stable medication regimen challenging to achieve. Here, Bool et al provides an overview of pharmacotherapy management of schizophrenia for family physicians through a case-based approach.</abstract><cop>Canada</cop><pub>College of Family Physicians of Canada</pub><pmid>33980630</pmid><doi>10.46747/cfp.6705350</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0008-350X |
| ispartof | Canadian family physician, 2021-05, Vol.67 (5), p.350-354 |
| issn | 0008-350X 1715-5258 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8115962 |
| source | EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
| subjects | Drug therapy Family physicians Patient care planning Prescription drugs Psychotropic drugs RxFiles Schizophrenia Side effects |
| title | Pharmacotherapy management of schizophrenia for family physicians |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T02%3A38%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacotherapy%20management%20of%20schizophrenia%20for%20family%20physicians&rft.jtitle=Canadian%20family%20physician&rft.au=Bool,%20Japheth&rft.date=2021-05&rft.volume=67&rft.issue=5&rft.spage=350&rft.epage=354&rft.pages=350-354&rft.issn=0008-350X&rft.eissn=1715-5258&rft_id=info:doi/10.46747/cfp.6705350&rft_dat=%3Cproquest_pubme%3E2526303775%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2536823131&rft_id=info:pmid/33980630&rfr_iscdi=true |